Intra-Tumoral Secondary Follicle-like Tertiary Lymphoid Structures Are Associated with a Superior Prognosis of Overall Survival of Perihilar Cholangiocarcinoma

Author:

Zhang Fa-PengORCID,Zhu Ke,Zhu Tai-Feng,Liu Chao-Qun,Zhang Hong-Hua,Xu Lei-Bo,Xiao Gang,Liu Chao

Abstract

Ectopic lymphoid structures termed tertiary lymphoid structures (TLSs) have an immunomodulatory function and positively affect prognosis in certain cancers. However, their clinical relevance and prognostic utility in perihilar cholangiocarcinoma (pCCA) are unknown. Therefore, determining the involvement and prognostic utility of TLSs in pCCA is the aim of this study. Ninety-three patients with surgically resected pCCA were included retrospectively. Hematoxylin and eosin and immunohistochemical staining identified and classified the TLSs, and multiplex immunofluorescence determined the TLS composition in the pCCA sample. The correlations between clinical features and TLSs were analyzed using either Fisher’s exact test or the Chi-squared test. Recurrence-free survival (RFS) and overall survival (OS) correlations with TLSs were analyzed using Cox regression and Kaplan–Meier analyses. We identified TLSs in 86% of patients with pCCA, including lymphoid aggregates (6.45%), primary (13.98%) and secondary follicles (65.59%). Patients with intra-tumoral secondary follicle-like TLSs (S-TLSs) had better OS (p = 0.003) and RFS (p = 0.0313). The multivariate analysis identified the presence of S-TLSs as a good independent prognostic indicator for OS but not for RFS. Interestingly, the presence of S-TLS only indicated better 5-year OS in 54 patients without lymph node metastasis (LNM−, p = 0.0232) but not in the 39 patients with lymph node metastasis (LNM+, p = 0.1244). Intra-tumoral S-TLSs predicted longer OS in patients with surgically resected pCCA, suggesting intra-tumoral S-TLSs’ contribution to effective antitumor immunity and that S-TLSs hold promise for diagnostic and therapeutic development in pCCA.

Funder

National Natural Science Foundation of China

Guangdong Basic and Applied Basic Research Foundation

Guangdong Medical Science and Technology Research Fund

Sun Yat-sen University Clinical Research 5010 Program

Science and Technology Program of Guangzhou

Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology

Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer

Guangdong Science and Technology Department

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cholangiocarcinoma;Razumilava;Lancet,2014

2. Emerging molecular therapeutic targets for cholangiocarcinoma;Rizvi;J. Hepatol.,2017

3. Klatskin Tumor;Siriwardena;J. Clin. Oncol.,2017

4. Cholangiocarcinoma 2020: The next horizon in mechanisms and management;Banales;Nat. Rev. Gastroenterol. Hepatol.,2020

5. Cholangiocarcinoma—evolving concepts and therapeutic strategies;Rizvi;Nat. Rev. Clin. Oncol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3